SCHEMBL3322133

SCHEMBL3322133

C#CCSc1cc(Cl)ccc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.41
MAPT P10636 2/20 0.41
CYP1A2 P05177 3/20 0.41
TDP1 Q9NUW8 3/20 0.41
CYP2D6 P10635 2/20 0.41
POLB P06746 2/20 0.39
HSP90AA1 P07900 2/20 0.38
HSP90AB1 P08238 1/20 0.38
HSP90B1 P14625 1/20 0.38
TRAP1 Q12931 1/20 0.38
PYCR1 P32322 1/20 0.37
KDM1A O60341 1/20 0.36
NR2F2 P24468 1/20 0.36
ALDH1A1 P00352 4/20 0.35
CYP3A4 P08684 4/20 0.35
CYP2C9 P11712 3/20 0.35
CYP2C19 P33261 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
HPGD P15428 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6541714 0.81 TDP1 (0.44) TP53MAPTCYP1A2TDP1CYP2D6
SCHEMBL1436075 0.72 CYP2D6 (0.50) TP53MAPTCYP1A2TDP1CYP2D6
SCHEMBL10959400 0.71 CA12 (0.53) TP53MAPTCYP1A2POLBPYCR1
SCHEMBL5185226 0.71 CYP1A2 (0.49) TP53MAPTCYP1A2TDP1CYP2D6
SCHEMBL18129367 0.71 CYP1A2 (0.49) TP53MAPTCYP1A2TDP1CYP2D6
SCHEMBL224923 0.69 TP53 (0.52) TP53MAPTCYP1A2TDP1CYP2D6
SCHEMBL7268486 0.69 HPGD (0.58) TP53MAPTTDP1CYP2D6POLB
SCHEMBL20873370 0.69 GRM5 (0.50) TP53MAPTTDP1CYP2D6POLB
SCHEMBL5853005 0.69 HPGD (0.47) TP53MAPTCYP1A2TDP1CYP2D6
SCHEMBL8599610 0.68 HTR2A (0.36) KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100120789-A1 Compound STERIX LIMITED (GB) 2010-05-13 US disclosed
US-20090042929-A1 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors STERIX LIMITED (GB) 2009-02-12 US disclosed
EP-1861384-A1 11-BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS Sterix Limited (GB) 2007-12-05 EP disclosed
WO-2006100502-A1 11-BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS STERIX LIMITED (GB) 2006-09-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042929-A1 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors HSD3B1, HSD3B2, HSD11B1 TP53 4150/4885MAPT 4815/4885CYP1A2 97/4885
US-20100120789-A1 Compound NR0B2, NR0B1, NR4A1 TP53 3914/4885MAPT 4740/4885CYP1A2 262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.